Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1820099
PUBLISHER: IMARC | PRODUCT CODE: 1820099
Bronchodilators Market Report by Indication (Asthma, Chronic Obstructive Pulmonary Disease, and Others), Drug Type, Route of Administration, and Region 2025-2033
PUBLISHED:
PAGES: 148 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global bronchodilators market size reached USD 39.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 57.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.15% during 2025-2033.
Bronchodilators are medications used to treat patients suffering from long-term conditions of narrow and inflamed airways, such as asthma, emphysema, and chronic obstructive pulmonary disease (COPD). They help relieve associated symptoms by relaxing the muscles around the airways or bronchi, clearing mucus from the lungs, and making breathing easier. They are available in the form of tablets, liquid, nebulizer solutions, and metered-dose and dry powder inhalers. Nowadays, bronchodilators are also utilized to enhance the effect of inhaled corticosteroids, which act as a primary treatment to reduce inflammation and prevent flare-ups in asthma.
Bronchodilators Market Trends:
A significantly rising number of patients with acute respiratory infections due to coronavirus disease (COVID-19) represents one of the key factors influencing the need for bronchodilators across the globe. Apart from this, increasing levels of air pollution, the rising number of smokers, and the growing prevalence of infectious diseases around the world are contributing to the risk of developing lung conditions. This is acting as another growth-inducing factor of the market. In addition, lung function declines gradually with age, which can make breathing slightly difficult. This, along with the increasing geriatric population and a considerable rise in consumer spending capacities, is driving the market. Other factors, such as improving healthcare infrastructure and diagnostic modalities and rising shift towards non-invasive procedures, are also propelling the market growth. Furthermore, several new classes of bronchodilators that can help overcome the limitations of existing products are in the preclinical phase stage. In confluence with this, health agencies of numerous countries are supporting research and development (R&D) activities for bronchodilators, which is anticipated to create a positive outlook for the market.
Key Market Segmentation:
Breakup by Indication:
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Others
Breakup by Drug Type:
- Sympathomimetics
- Anticholinergics
- Phosphodiesterase Inhibitor
- Combination Drugs
Breakup by Route of Administration:
- Oral
- Injection
- Inhaler
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd. and Vectura Group plc.
Key Questions Answered in This Report
- 1.How big is the global bronchodilators market?
- 2.What is the expected growth rate of the global bronchodilators market during 2025-2033?
- 3.What are the key factors driving the global bronchodilators market?
- 4.What has been the impact of COVID-19 on the global bronchodilators market?
- 5.What is the breakup of the global bronchodilators market based on the indication?
- 6.What is the breakup of the global bronchodilators market based on the drug type?
- 7.What is the breakup of the global bronchodilators market based on the route of administration?
- 8.What are the key regions in the global bronchodilators market?
- 9.Who are the key players/companies in the global bronchodilators market?
Product Code: SR112025A4184
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Bronchodilators Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Indication
- 6.1 Asthma
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Chronic Obstructive Pulmonary Disease (COPD)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Drug Type
- 7.1 Sympathomimetics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Anticholinergics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Phosphodiesterase Inhibitor
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Combination Drugs
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Route of Administration
- 8.1 Oral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Injection
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Inhaler
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 AstraZeneca plc
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Boehringer Ingelheim International GmbH
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 F. Hoffmann-La Roche Ltd
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 SWOT Analysis
- 14.3.5 GlaxoSmithKline plc
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Novartis AG
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Pfizer Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Sanofi
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Teva Pharmaceutical Industries Ltd.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Vectura Group plc
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 Abbott Laboratories
Product Code: SR112025A4184
List of Figures
- Figure 1: Global: Bronchodilators Market: Major Drivers and Challenges
- Figure 2: Global: Bronchodilators Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Bronchodilators Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Bronchodilators Market: Breakup by Indication (in %), 2024
- Figure 5: Global: Bronchodilators Market: Breakup by Drug Type (in %), 2024
- Figure 6: Global: Bronchodilators Market: Breakup by Route of Administration (in %), 2024
- Figure 7: Global: Bronchodilators Market: Breakup by Region (in %), 2024
- Figure 8: Global: Bronchodilators (Asthma) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Bronchodilators (Asthma) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease - COPD) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease - COPD) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Bronchodilators (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Bronchodilators (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Bronchodilators (Sympathomimetics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Bronchodilators (Sympathomimetics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Bronchodilators (Anticholinergics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Bronchodilators (Anticholinergics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Bronchodilators (Combination Drugs) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Bronchodilators (Combination Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Bronchodilators (Oral) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Bronchodilators (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Bronchodilators (Injection) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Bronchodilators (Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Bronchodilators (Inhaler) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Bronchodilators (Inhaler) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: North America: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: North America: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: United States: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: United States: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Canada: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Canada: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: Asia-Pacific: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: Asia-Pacific: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: China: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: China: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: Japan: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: Japan: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: India: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: India: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: South Korea: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: South Korea: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: Australia: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: Australia: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: Indonesia: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: Indonesia: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Others: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Others: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: Europe: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: Europe: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Germany: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Germany: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: France: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: France: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: United Kingdom: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: United Kingdom: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Italy: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Italy: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Spain: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Spain: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Russia: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Russia: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Others: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Others: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Latin America: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Latin America: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Brazil: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Brazil: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Mexico: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Mexico: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Others: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Others: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Middle East and Africa: Bronchodilators Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Middle East and Africa: Bronchodilators Market: Breakup by Country (in %), 2024
- Figure 76: Middle East and Africa: Bronchodilators Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 77: Global: Bronchodilators Industry: SWOT Analysis
- Figure 78: Global: Bronchodilators Industry: Value Chain Analysis
- Figure 79: Global: Bronchodilators Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Bronchodilators Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Bronchodilators Market Forecast: Breakup by Indication (in Million USD), 2025-2033
- Table 3: Global: Bronchodilators Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
- Table 4: Global: Bronchodilators Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
- Table 5: Global: Bronchodilators Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Bronchodilators Market: Competitive Structure
- Table 7: Global: Bronchodilators Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.